Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IL/Peoria
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Peoria, IL

Studies commonly pay $75 to $4,500 per completed study

221 clinical trials are currently recruiting participants within 30 miles of Peoria. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

221studies recruiting
3+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Peoria right now

Top 25 of 221 recruiting studies, sorted by proximity — each links to its official registry page

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,900 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought
Illinois Cancer Care — Peoria, Illinois (4.3 mi) · Sponsor: SCRI Development Innovations, LLC

Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor

Perinatal Decision Making N/A Interventional 2,200 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi) · Sponsor: Endeavor Health

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Peoria, Illinois (4.3 mi) · Sponsor: Daiichi Sankyo

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Pancreatic Cancer, Pancreatic Cancer Metastatic Phase 3 Interventional 570 participants sought
OSF Medical Center — Peoria, Illinois (4.3 mi) · Sponsor: Immuneering Corporation

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: SWOG Cancer Research Network

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

Lower Extremity Acute Limb Ischemia, LE ALI N/A Observational 300 participants sought
OSF Saint Francis Medical Center — Peoria, Illinois (4.3 mi) · Sponsor: Penumbra Inc.

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma Phase 3 Interventional 562 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: SWOG Cancer Research Network

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Phase 2 Interventional 48 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi) · Sponsor: National Cancer Institute (NCI)

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms Phase 3 Interventional 1,314 participants sought
Illinois Cancer Care ( Site 0104) — Peoria, Illinois (4.3 mi) · Sponsor: Merck Sharp & Dohme LLC

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: NRG Oncology

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi) · Sponsor: National Cancer Institute (NCI)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Multiple conditions Phase 2 Interventional 98 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: NRG Oncology

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: SWOG Cancer Research Network

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Obesity, Heart Failure Phase 3 Interventional 5,610 participants sought
Methodist Medical Center of Illinois — Peoria, Illinois (4.3 mi) · Sponsor: Novo Nordisk A/S

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Locally Advanced Breast Cancer Phase 3 Interventional 1,000 participants sought
Clinical Trial Site — Peoria, Illinois (4.3 mi) · Sponsor: Olema Pharmaceuticals, Inc.

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Renal Pelvis and Ureter Urothelial Carcinoma Phase 2, Phase 3 Interventional 131 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: National Cancer Institute (NCI)

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Non-Small Cell Lung Cancer, NSCLC Phase 1 Interventional 665 participants sought
OSF Healthcare Cancer Institute — Peoria, Illinois (4.3 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: NRG Oncology

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Metastatic Colorectal Cancer Phase 3 Interventional 1,020 participants sought
Illinois CancerCare PC — Peoria, Illinois (4.3 mi) · Sponsor: EMD Serono Research & Development Institute, Inc.

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi) · Sponsor: National Cancer Institute (NCI)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi) · Sponsor: National Cancer Institute (NCI)
Actively enrolling

Studies you may be able to join near Peoria

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Peoria

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Optimal Research

★ 4.6
4911 N Executive Dr 2nd floor, Peoria, IL 61614
(309) 672-1910
"I did a flu study. I got sick - they told me I wasn’t sick. I know sick. In my opinion, this is their way of manipulating results & I would never tru…"
— gayla martindale, 1★

Koch Clinical Research

★ 5.0
411 Maxine Dr, Morton, IL 61550
(309) 291-0585
"The facility was very clean and organized, and the staff was very kind and helpful."
— Laura, 5★

Illinois CancerCare - Peoria

★ 3.4 (52 reviews)
8940 Wood Sage Rd, Peoria, IL 61615
(309) 240-6388
"I absolutely love this place I have been going here for my iron transfusions for a while now, and if you dont know what those are you need to Google …"
— Brittney lawson, 5★

Clinical trials in Peoria: what's recruiting

The Peoria area currently has 221 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Peoria, the most active research areas are:

  • Cancer & Oncology20 studies
  • Liver & Kidney2 studies
  • Lungs & Breathing1 studies
  • Heart & Vascular1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Peoria, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Peoria

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Peoria participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Peoria?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Peoria safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Peoria?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Peoria typically complete one or two studies per year.

Paid clinical trials near Peoria

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of IL

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts